Astrazeneca Pharma India Ltd
NSE:ASTRAZEN
Decide at what price you'd be comfortable buying and we'll help you stay ready.
Intrinsic Value
The intrinsic value of 
Astrazeneca Pharma India Ltd (ASTRAZEN) under the Base Case is 13 234.87 INR per share.
Compared with the current market price of 6 438.5 INR, the stock appears
Undervalued by 51% .
The intrinsic value is calculated using the DCF method. The model mostly extends the recent record: revenue grows about 21% a year over the next five years, against 23% over the last five, and operating margin stays near last year's 10%.
Do our valuations actually work? See backtest results .
Cheap or expensive for this stock?
This block shows whether today’s valuation is cheap or expensive compared with the stock’s own history, and what happened after similar valuations in the past.
We compare the gap between the stock’s price and our estimated value over time.
- Undervalued can still be historically expensive. The stock may trade below our estimated value, but usually offer an even bigger discount.
- Overvalued can still be historically cheap. The stock may trade above our estimated value, but usually carry an even higher premium.
Market expectations can differ from our model, which may not fully capture everything affecting the price. That is why some stocks regularly trade above our estimated value and others below it.
The scale and chart show how today’s valuation compares with the past. The cards summarize past returns and waiting times until the stock stopped being cheap or expensive. This can happen because the price changed, our estimated value changed, or both.
Only completed periods are included. These are past results, not forecasts. The usual historical range does not necessarily mean fair value.
Fundamental Analysis
What Astrazeneca Pharma India Does
AstraZeneca Pharma India Ltd sells prescription medicines in India, with a focus on specialty drugs for areas such as oncology, cardiovascular and kidney care, respiratory disease, and other chronic conditions. It does not manufacture most of these drugs in the way a generic maker does; instead, it markets and distributes branded medicines developed by the AstraZeneca group and supports doctors and healthcare providers with product information and medical education.
- Headquarters
- India IN
- Employees
- 600
- IPO date
- Jul 30, 1998
Revenue & Expenses Breakdown
Astrazeneca Pharma India Ltd
Earnings Waterfall
Astrazeneca Pharma India Ltd
What is the Intrinsic Value of one ASTRAZEN stock?
The intrinsic value for Astrazeneca Pharma India Ltd (ASTRAZEN) under the Base Case is 13 234.87 INR.
Is ASTRAZEN stock undervalued or overvalued?
Compared with the current market price of 6 438.5 INR, the stock appears Undervalued by 51% .
